Hu Danqing, Huang Zhengxing, Chan Tak-Ming, Dong Wei, Lu Xudong, Duan Huilong
College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, Zhejiang, China.
Health Systems, Philips Research China, Shanghai, China.
Stud Health Technol Inform. 2017;245:398-402.
Clinical risk prediction of acute coronary syndrome (ACS) plays a critical role for clinical decision support, treatment management and quality of care assessment in ACS patients. Admission records contain a wealth of patient information in the early stages of hospitalization, which offers the opportunity to support the ACS risk prediction in a proactive manner. However, ACS patient risks aren't recorded in hospital admission records, thus impeding the construction of supervised risk prediction models. In our study, we propose a novel approach for ACS risk prediction, which employs a well-known ACS risk prediction model (GRACE) as the benchmark methods to stratify patient risks, and then utilizes a state-of-the-art supervised machine learning algorithm to establish our risk prediction models. The experiment was conducted with a collection of 3,643 ACS patient samples from a Chinese hospital. Our best model achieved 0.616 accuracy for risk prediction, which indicates our learned model can achieve a better performance than the benchmark GRACE model and can obtain significant improvement by mixing up patient samples that were manually labeled risks.
急性冠状动脉综合征(ACS)的临床风险预测在ACS患者的临床决策支持、治疗管理和护理质量评估中起着关键作用。入院记录在住院早期包含了丰富的患者信息,这为以积极主动的方式支持ACS风险预测提供了机会。然而,ACS患者风险并未记录在医院入院记录中,从而阻碍了监督风险预测模型的构建。在我们的研究中,我们提出了一种用于ACS风险预测的新方法,该方法采用一种著名的ACS风险预测模型(GRACE)作为基准方法对患者风险进行分层,然后利用一种先进的监督机器学习算法来建立我们的风险预测模型。实验使用了来自一家中国医院的3643例ACS患者样本进行。我们的最佳模型在风险预测方面达到了0.616的准确率,这表明我们学习到的模型比基准GRACE模型能取得更好的性能,并且通过混合人工标记风险的患者样本可以获得显著改进。